Key facts
- Thymia’s last known valuation is $26.2M.
- It has raised $11.8M; the latest was Early Stage VC ($6.4M) in Oct 2024.
- Notable investors include Innovate UK, Entrepreneurs First, Village Capital, London & Partners., Texas Medical Center — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Thymia
- ·The full record, as it builds
Funding rounds
No funding rounds for Thymia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Thymia
Developer of video games designed to make mental health as objectively measurable as physical health. The company's platform uses video games based on neuropsychology alongside analyses of video and speech to make mental health assessments, offering a multi-modal depression recognition and tracking system that allows for rapid treatment decisions, enabling clinicians to assess depression more accurately and objectively.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2020
- Employees
- 31
- Website
- thymia.ai/
- Ownership
- Privately Held (backing)
Thymia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Thymia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Thymia in its N-PORT filings yet. We sweep new filings monthly.